Redhill Biopharma Patents – Insights & Stats (Updated 2024)

Redhill Biopharma has a total of 293 patents globally, out of which 183 have been granted. Of these 293 patents, more than 66% patents are active. United States of America is where Redhill Biopharma has filed the maximum number of patents, followed by China and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of Redhill Biopharma.

Redhill Biopharma was founded in 2009. Redhill Biopharma is a biopharmaceutical company specializing in gastrointestinal diseases. They offer drugs such as Movantik for opioid-induced constipation, Talicia for Helicobacter pylori infections, and Aemcolo for travelers’ diarrhea in adults.

Do read about some of the most popular patents of Redhill Biopharma which have been covered by us in this article and also you can find Redhill Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Redhill Biopharma patent portfolio.

How many patents does Redhill Biopharma have?

Redhill Biopharma has a total of 293 patents globally. These patents belong to 20 unique patent families. Out of 293 patents, 194 patents are active.

How Many Patents did Redhill Biopharma File Every Year?

Redhill Biopharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRedhill Biopharma Applications FiledRedhill Biopharma Patents Granted
20243
2023513
202234
20213022
2020830
20192045
20182014
20171016
20161911
2015405
2014542

How many Redhill Biopharma patents are Alive/Dead?

Worldwide Patents

Redhill Biopharma Patent Porfolio

How Many Patents did Redhill Biopharma File in Different Countries?

Redhill Biopharma Worldwide Patent Filing

Countries in which Redhill Biopharma Filed Patents

CountryPatent
United States of America50
China16
Japan14
Australia14
Europe (EPO)14
Canada12
Israel11
Hong Kong (S.A.R.)11
Mexico10
Korea (South)10
Brazil9
Germany8
South Africa8
Philippines8
Austria7
Russian Federation7
Singapore6
Denmark6
Chile5
Spain5
India5
Norway5
Turkey5
New Zealand4
Slovenia4
Hungary4
Poland4
Portugal4
Cyprus3
Croatia3
Indonesia2
Italy2
Slovakia2
Estonia1
United Kingdom1
Malta1
Ukraine1
Taiwan1

Where are Research Centers of Redhill Biopharma Patents Located?

R&D Centres of Redhill Biopharma

10 Best Redhill Biopharma Patents

US7467202B2 is the most popular patent in the Redhill Biopharma portfolio. It has received 229 citations so far from companies like Company, Research, Mcafee.

Below is the list of 10 most cited patents of Redhill Biopharma:

Publication NumberCitation Count
US9050263B210
US20140271851A18
US8343511B27
USD883801S17
US9498445B26
US10238606B25
US11045453B15
US9844540B25
CN110785172A5
WO2016063134A15

What are Redhill Biopharma key innovation segments?

What Technologies are Covered by Redhill Biopharma?

The chart below distributes patents filed by Redhill Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Redhill Biopharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Redhill Biopharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Redhill Biopharma?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.